Should I buy Teradyne (TER) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 71% of its targets hit on this sector (217 calls tested). It aims for $550 (+45 %), call made on July 30, 2026, maturing on July 30, 2027 (76 d ago).
Firm-by-firm track record on Teradyne
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 57 % | +111.2 % | 7 | $400 +5% |
| Baird | 80 % | +45.1 % | 10 | $420 +10% |
| Susquehanna | 53 % | +38.4 % | 17 | $550 +45% |
| UBS | 52 % | +32.1 % | 21 | $500 +31% |
| Citigroup | 59 % | +29.3 % | 17 | $400 +5% |
| Craig-Hallum | 75 % | +15.3 % | 8 | $111 -71% |
| Stifel | 67 % | +15.1 % | 9 | $390 +3% |
| Evercore ISI Group | 40 % | +7.0 % | 5 | $420 +10% |
✅ Reasons to believe
- 82% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
- Median price target $420, i.e. +10% from the current price ($380).
- The most reliable firm on TER, Baird (80% hit rate, 10 scored calls), targets $420 (call made on August 21, 2026, maturing on August 21, 2027) (+10%) in its most recent call, and $332 (call made on March 30, 2026, maturing on March 30, 2027) (-13%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 11 ratings, 2 are neutral.
- High valuation (P/E ~52): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- Negligible dividend (0.1% yield): your return depends mostly on price appreciation.
The analyst consensus on TER
Median target $420 (+10%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Teradyne now?
We won't decide for you. The facts: 82% of analysts rate it a buy, median target $420 (+10%), and Baird (most reliable on TER, 80%) targets $420. Weigh that against valuation (P/E ~52) and volatility. This is not personalized advice.
Is it too late to invest in Teradyne?
Not according to analysts: the median target ($420) is still +10% above the current price ($380) (most reliable on TER: Baird, 80%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Teradyne still worth investing in?
It depends on the gap between the price ($380) and its estimated value: analysts target $420 on median (+10%), with 82% buys (most reliable on TER: Baird, 80%). Cross-check with their real reliability on TER and the cautions above. Information, not advice.
What's the main risk in buying TER?
The consensus is not unanimous: of 11 ratings, 2 are neutral.
→ Go deeper: the full Teradyne profile (consensus, analyst reliability, price target, performance).